Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

Develops and markets medications used in the fields of neurology, dermatology and infectious diseases.

  • Edit
More about Valeant Pharmaceuticals International
Made with AI
Edit

Bausch Health Companies Inc. operates as a global leader in the healthcare sector, focusing on pharmaceuticals, medical devices, and over-the-counter consumer health products. Serving a diverse range of clients, including hospitals, healthcare providers, and individual consumers, Bausch Health aims to improve lives through its extensive portfolio of products. The company operates in various markets worldwide, leveraging its broad distribution network to reach over 150 million people daily. Bausch Health's business model revolves around the development, manufacturing, and marketing of its healthcare products, generating revenue through direct sales and partnerships with healthcare institutions. The company continues to gain momentum, positioning itself as a turnaround opportunity with significant growth potential.

Keywords: pharmaceuticals, medical devices, consumer health, global leader, healthcare products, hospitals, healthcare providers, individual consumers, distribution network, turnaround opportunity.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit

Investments by Valeant Pharmaceuticals International

Edit
Bausch & Lomb
ACQUISITION by Valeant Pharmaceuticals International May 2013
LipoSonix
ACQUISITION by Valeant Pharmaceuticals International Jun 2008
Private Formula International Holdings
ACQUISITION by Valeant Pharmaceuticals International Sep 2009
Revance Therapeutics
ACQUISITION by Crown Laboratories Aug 2024
Aton Pharma
ACQUISITION by Valeant Pharmaceuticals International May 2010
PreCision Dermatology
ACQUISITION by Valeant Pharmaceuticals International Feb 2014
Sprout Pharmaceuticals
ACQUISITION by Valeant Pharmaceuticals International Aug 2015
DermTech
ACQUISITION Sep 2024
Ascent Pediatrics
ACQUISITION by Valeant Pharmaceuticals International Nov 2001
Xcel Pharmaceuticals
ACQUISITION by Valeant Pharmaceuticals International Feb 2005
View 4 more